Your session is about to expire
← Back to Search
Other
Geranylgeraniol Treatment for Sexual Wellness
N/A
Waitlist Available
Research Sponsored by Applied Science & Performance Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4 and 8
Summary
This trial tests a dietary supplement called Geranylgeraniol to see if it can improve sexual health in males and females. The supplement might help by balancing hormones and improving physical health.
Eligible Conditions
- Sexual Wellness
- Low Sex Drive
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 4 and 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4 and 8
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in Aging Male Symptoms
Changes in Androgen Deficiency in Aging Males Scale
Changes in Erectile Function
+6 moreSecondary study objectives
Changes in Alanine Transaminase levels
Changes in Albumin levels
Changes in Albumin to Globulin ratio
+54 moreOther study objectives
Adverse Effects
Resting Diastolic Blood Pressure
Resting Systolic Blood Pressure
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Geranylgeraniol TreatmentExperimental Treatment1 Intervention
From weeks 1-4, participants will consume 150mg daily of a Geranylgeraniol (GG). For weeks 5-8, the dose will be escalated as participants will consume 300mg daily of GG.
Group II: PlaceboPlacebo Group1 Intervention
From weeks 1-4, participants will consume 150mg daily of a visually identical placebo. For weeks 5-8, the dose will be escalated as participants will consume 300mg daily of placebo supplementation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GG sourced from Annatto
2022
N/A
~90
Find a Location
Who is running the clinical trial?
Applied Science & Performance InstituteLead Sponsor
14 Previous Clinical Trials
811 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger